Abstract
Ganoderma lucidum is traditionally applied in various countries for treatment of variety of diseases. It is a prime example of an ancient remedy being of immense relevance to the modern era and known as mushroom of immortality as well as spirit mushroom. It has been used as a health promoting agent due to its wide pharmacological and nutraceutical activity and availability. Increasing awareness about fitness and health-promoting capability of G. lucidum pull the majority of people to get healthier lifestyles, propelling expansion of its market globally. The importance of Ganoderma lucidum has fascinated scientific community to carry out extensive phytochemical and pharmacological investigations. Different studies have been carried out, and a broad spectrum of its pharmacological actions has been established which include immunomodulatory, anticancerous, antioxidant, antidiabetic, hepatoprotective, neuroprotective, cardioprotective, antimicrobial, anti-inflammatory, anti-allergic, antiosteoporotic, suppression of angiogenesis, and antinociceptive properties. The current review is an attempt to explore the reported chemical composition and pharmacological activity. It will act as a reference for all researchers, scientists, and other health professionals who are working on this mushroom.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmad MF (2018) Ganoderma lucidum: Persuasive biologically active constituents and their health endorsement. Biomed Pharmacother 107:507–519
Ahmad MF, Ashraf SA, Ahmad FA, Ansari JA, Siddiquee MRA (2011) Nutraceutical market and its regulation. Am J Food Technol 6:342–347
Ahmad MF, Ahmad FA, Azad Z, Ahmad A, Alam MI, Ansari JA, Panda BP (2013a) Edible mushrooms as health promoting agent. Adv Sci Focus 1(3):189–196
Ahmad MF, Ahmad FA, Azad ZRAA, Alam MS, Ashraf SA (2013b) Nutraceutical is the need of hour. WJPPS 2:2516–2525
Ahmad MF, Panda BP, Azad ZRAA (2013c) Simultaneous bioprospecting of Ganoderma lucidum OE 52 with ganoderic acid B and C2 by submerged fermentation process. Adv Sci Focus 1:1–4
Akbar R, Yam WK (2011) Interaction of ganoderic acid on HIV related target: molecular docking studies. Bioinformation 7(8):413–417
Akihisa T, Nakamura Y, Harukuni MT, Yasukawa TK, Uchiyama E, Suzuki T, Kimura Y (2007) Anti-inflammatory and anti-tumor-promoting effects of triterpene acids and sterols from the fungus Ganoderma lucidum. Chem Biodivers 4:224–231
Alvarez SPO, Cadavid DAR, Sierra DME, Orozco CPO, Vahos DFR, Ocampo PZ, Atehortua L (2014) Comparison of extraction methods of chitin from Ganoderma lucidum mushroom obtained in submerged culture. BioMed Res Int 2014:1–7
Babu PD, Subhasree RS (2008) The sacred mushroom reishi. Am Euras J Bot 1:107–110
Barbieri A, Quagliariello V, Del Vecchio V, Falco M, Luciano A, Amruthraj NJ, Nasti G, Ottaiano A, Berretta M, Iaffaioli RV, Arra C (2017) Anticancer and anti-inflammatory properties of Ganoderma lucidum extract effects on melanoma and triple-negative breast cancer treatment. Nutrients 9(3):210
Berger A, Rein D, Kratky E, Monnard I, Hajjaj H, Meirim I, Piguet-Welsch I, Hauser J, Mace K, Niederberger P (2004) Cholesterol-lowering properties of Ganoderma lucidum in vitro, ex vivo, and in hamsters and minipigs. Lipids Health Dis 3:2
Bisen PS, Baghel RK, Sanodiya BS, Thakur GS, Prasad GB (2010) Lentinus edodes: a macrofungus with pharmacological activities. Curr Med Chem 17(22):2419–2430
Boh B, Hodzar D, Berovic M, Pohleven F (2000) Isolation and quantification of triterpenoid acids from Ganoderma applanatum of istrian origin. Food Technol Biotechnol 38:11–18
Cai Z, Wong CK, Dong J, Jiao D, Chu M, Leung PC, Lam CWK (2016) Anti-inflammatory activities of Ganoderma lucidum (Lingzhi) and San-Miao-San supplements in MRL/lpr mice for the treatment of systemic lupus erythematosus. Chin Med 11(1):23
Cao QZ, Lin ZB (2006) Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular endothelial cell and the induction of VEGF in human lung cancer cell. Life Sci 78(13):1457–1463
Cao PF, Wu CG, Dang ZH, Shi L, Jiang AL, Ren A, Zhao MW (2017) Effects of exogenous salicylic acid on ganoderic acid biosynthesis and the expression of key genes in the ganoderic acid biosynthesis pathway in the lingzhi or reishi medicinal mushroom, Ganoderma lucidum (Agaricomycetes). Int J Med Mushrooms 19(1):65
Chang R (2002) Bioactive polysaccharides from traditional Chinese medicine herbs as anticancer adjuvants. Altern Complement Med 8:559–565
Chang ST, Buswell JA (1999) Ganoderma lucidum (Curt.:Fr) P. Karst. (Aphyllophoromycetideae)—a mushrooming medicinal mushroom. Int J Med Mushrooms 1:139–146
Chang ST, Buswell JA (2003) Medicinal mushrooms—a prominent source of nutriceuticals for the 21st century. Curr Top Nutraceut Res 1:257–280
Chen R, Yu D (1990) Development of triterpenes from Ganoderma lucidum. Acta Pharm Sin 25:940–953
Chen WC, Hau DM, Lee SS (1995) Effect of Ganoderma lucidum and krestin on cellular immunocompetence in gamma-ray-irradiated mice. J Chin Med 23:71–80
Chen NH, Liu JW, Zhong J (2010) Ganoderic acid T inhibits tumor invasion in vitro and in vivo through inhibition of MMP expression. J Pharmacol Rep 62:150–163
Cheng HH, Hou WC, Lu ML (2002) Interactions of lipid metabolism and intestinal physiology with tremella fuciformis berk edible mushroom in rats fed a high-cholesterol diet with or without nebacitin. J Agric Food Chem 50:7438–7443
Cheuk W, Chan JK, Nuovo G, Chan MK, Fok M (2007) Regression of gastric large B-cell lymphoma accompanied by a florid lymphoma-like T-cell reaction: immunomodulatory effect of Ganoderma lucidum (Lingzhi). Int J Surg Pathol 15:180–186
Chiu SW, Wang ZM, Leung TM, Moore D (2000) Nutritional value of Ganoderma extract and assessment of its genotoxicity and antigenotoxicity using comet assays of mouse lymphocytes. Food Chem Toxicol 38:173–178
Chu QP, Wang LE, Cui XY, Fu HZ, Lin ZB, Lin SQ, Zhang YH (2007) Extract of Ganoderma lucidum potentiates pentobarbital-induced sleep via a GABAergic mechanism. Pharmacol Biochem Behav 86:693–698
Chu TT, Benzie IF, Lam CW, Fok BS, Lee KK, Tomlinson B (2012) Study of potential cardioprotective effects of Ganoderma lucidum (Lingzhi): results of a controlled human intervention trial. Br J Nutr 107(7):1017–1027
De Baets S, Vandamme J (2001) Extracellular tremella polysaccharides: structures, properties and application. Biotechnol Lett 23:1361–1366
Deepalakshmi K, Mirunalini S (2011) Therapeutic properties and current medical usage of medicinal mushroom: Ganoderma lucidum. Int J Pharm Sci Res 2:1922–1929
Elhassaneen YA, Ragab SS, Salman MS (2016) The potential effects of reishi mushroom (Ganoderma lucidum) consumption on bone health indices and serum minerals profile disorders induced by CCl4 on rats. PJMPR 2(1):001–007
El-Mekkawy S, Meselhy MR, Nakamura N, Tezuka Y, Hattori M, Kakiuchi N, Shimotohno K, Kawahata T, Otake T (1998) Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum. Phytochemistry 49(6):1651–1657
Fatmawati S, Shimizu K, Kondo R, Ganoderol B (2011) A potent α-glucosidase inhibitor isolated from the fruiting body of Ganoderma lucidum. Phytomedicine 18(12):1053–1055
Feng X (1995) Glossy Ganoderma tea and its preparation method. CN patent no. 1105523
Fujita R, Liu J, Shimizu K, Konishi F, Noda K, Kumamoto S, Ueda C, Tajiri H, Kaneko S, Suimi Y, Kondo R (2005) Anti-androgenic activities of Ganoderma lucidum. J Ethnopharmacol 102(1):107–112
Fujiwara H, Sawai T (1993) Food or beverage for improving saccharide metabolism. JP patent no. 5124974
Fukushima M, Nakano M, Morii Y, Ohashi T, Fujiwara Y, Sonoyama K (2000) Hepatic LDL receptor mRNA in rats is increased by dietary mushroom (Agaricus bisporus) fiber and sugar beet fiber. J Nutr 130:2151–2156
Fukuzawa M, Yamaguchi R, Hide I, Chen Z, Hirai Y, Sugimoto A, Yasuhara T, Nakata Y (2008) Possible involvement of long chain fatty acids in the spores of Ganoderma lucidum (Reishi Houshi) to its anti-tumor activity. Biol Pharm Bull 31:1933–1937
Gao RQ (1996) Glossy Ganoderma extract and glossy Ganoderma beer. CN patent no. 1115612
Gao Y, Zhou S, Jiang W, Huang M, Dai X (2003a) Effects of ganopoly (Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest 32:201–215
Gao Y, Zhou S, Huang M, Xu A (2003b) Antibacterial and antiviral value of the genus Ganoderma P. Karst. Species (Aphyllophoromycetideae) a review. Int J Med Mushrooms 5:235 246
Gao Y, Chen G, Dai X, Ye J, Zhou S (2004a) A phase I/II study of ling zhi mushroom Ganoderma lucidum (W.Curt.:Fr.) Lloyd (Aphyllophoromycetideae) extract in patients with coronary heart disease. Int J Med Mushrooms 6:30
Gao Y, Lan J, Dai X, Ye J, Zhou S (2004b) A phase I/II study of ling zhi mushroom Ganoderma lucidum (W.Curt.:Fr.) Lloyd (Aphyllophoromycetidae) extract in patients with type II diabetes mellitus. Int J Med Mushrooms 6:33–42
Gao Y, Tang W, Dai X, Gao H, Chen G, Ye J, Chan E, Koh HL, Li X, Zhou S (2005) Effects of water-soluble Ganoderma lucidum polysaccharides on the immune functions of patients with advanced lung cancer. J Med Food 8:159–168
Gau JP, Lin CK, Lee SS, Wang SR (1990) The lack of antiplatelet effect of crude extracts from Ganoderma lucidum on HIV-positive hemophiliacs. Am J Chin Med 18:175–179
Gill BS, Kumar S (2015) Differential algorithms-assisted molecular modeling-based identification of mechanistic binding of ganoderic acids. Med Chem Res 24(9):3483–3493
Gill BS, Sharma P, Kumar R, Kumar S (2016a) Misconstrued versatility of Ganoderma lucidum: a key player in multi-targeted cellular signaling. Tumor Biol 37(3):2789–2804
Gill BS, Sharma P, Kumar S (2016b) Chemical composition and antiproliferative, antioxidant, and proapoptotic effects of fruiting body extracts of the lingzhi or reishi medicinal mushroom, Ganoderma lucidum (Agaricomycetes), from India. Int J Med Mushrooms 18(7):599–607
Haak-Frendscho M, Kino K, Sone T, Jardieu P (1993) Ling Zhi-8: a novel T cell mitogen induces cytokine production and upregulation of ICAM-1 expression. Cell Immunol 150:101–113
Hajjaj H, Mace C, Roberts M, Niederberger P, Fay LB (2005) Effect of 26-oxygenosterols from Ganoderma lucidum and their activity as cholesterol synthesis inhibitors. Appl Environ Microbiol 71(7):3653–3658
Heleno SA, Ferreira IC, Esteves AP, Ciric A, Glamoclija J, Martins A, Sokovic M, Queiroz MJ (2013) Antimicrobial and demelanizing activity of Ganoderma lucidum extract, p-hydroxybenzoic and cinnamic acids and their synthetic acetylated glucuronide methyl esters. Food Chem Toxicol 58:95–100
Hikino H, Konno C, Mirin Y, Hayashi T (1985) Isolation and hypoglycaemic activities of ganoderans A and B, glucans of Ganoderma lucidum fruit bodies. Planta Med 51:339–340
Hirotani M, Furuya T (1986) Ganoderic acid derivatives, highly oxygenated lanostane-type triterpenoids, from Ganoderma lucidum. Phytochemistry 25(5):1189–1193
Ho YW, Yeung JS, Chiu PK, Tang WM, Lin ZB, Man RY, Lau CS (2007) Ganoderma lucidum polysaccharide peptide reduced the production of proinflammatory cytokines in activated rheumatoid synovial fibroblast. Mol Cell Biochem 301:173–182
Hsu CC, Chen C-H, Hsu T-I, Hung J-J, Ko J-L, Zhang B et al (2014) The 58-kDa microspherule protein (MSP58) represses human telomerase reverse transcriptase (hTERT) gene expression and cell proliferation by interacting with telomerase transcriptional element-interacting factor (TEIF). Biochim Biophys Acta 1843(3):565–579
Huang HC, Liu YC (2008) Enhancement of polysaccharide production by optimization of culture conditions in shake flask submerged cultivation of Grifola umbellate. J Chin Inst Chem Eng 39:307–311
Huang L, Sun F, Liang C, He YX, Bao R, Liu L, Zhou CZ (2009) Crystal structure of LZ-8 from the medicinal fungus Ganoderma lucidum. Proteins 75(2):524–527
Huie CW, Di X (2004) Chromatographic and electrophoretic methods for lingzhi pharmacologically active components. J Chromatogr B 812:241–257
Ishimoto Y, Ishibashi KI, Yamanaka D, Adachi Y, Ito H, Igami K, Miyazaki T, Ohno N (2017) Enhanced release of immunostimulating β-1,3-glucan by autodigestion of the lingzhi medicinal mushroom, Ganoderma lingzhi (Agaricomycetes). Int J Med Mushrooms 19(1):1
Israilides C, Kletsas D, Arapoglou D (2008) In vitro cytostatic and immunomodulatory properties of the medicinal mushroom Lentinula edodes. Phytomedicine 15:512–519
Ji Z, Tang Q, Zhang J, Yang Y, Jia W, Pan Y (2007) Immunomodulation of RAW264.7 macrophages by GLIS, a proteopolysaccharide from Ganoderma lucidum. J Ethnopharmacol 112(3):445–450
Jia W, Wu M, Zhang JS, Liu YF (2005) A preliminary study on the sleep-improvement function of the effective ingredients of Ganoderma lucidum fruitbody. Acta Edulis Fungi 12:43–47
Jiang J, Slivova V, Valachovicova T, Harvey K, Sliva D (2004) Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3. Int J Oncol 24(5):1093–1099
Jin X, Ruiz Beguerie J, Sze DM, Chan GC (2016) Ganoderma lucidum (Reishi mushroom) for cancer treatment. The Cochrane Library
Jonathan SG, Bawo DD, Adejoye DO, Briyai OF (2009) Studies on biomass production in Auricularia polytricha collected from Wilberforce Island, Bayelsa State, Nigeria. Am J Appl Sci 6(1):182–186
Joseph S, Sabulal B, George V, Smina TP, Janardhanan KK (2009) Antioxidative and antiinflammatory activities of the chloroform extract of Ganoderma lucidum found in South India. Sci Pharm 77:111–121
Kao CHJ, Jesuthasan AC, Bishop KS, Glucina MP, Ferguson LR (2013) Anti-cancer activities of Ganoderma lucidum: active ingredients and pathways. Funct Foods Health Dis 3:48–65
Kawagishi H, Fukuhara F, Sazuka M, Kawashima A, Mitsubori T, Tomita T (1993) 50-Deoxy-50-methylsulphinyladenosine, a platelet aggregation inhibitor from Ganoderma lucidum. Phytochemistry 32:239–241
Khatun S, Islam A, Cakilcioglu U, Chatterjee NC (2012) Research on mushroom as a potential source of nutraceuticals: perspective. Am J Exp Agric 2:47–73
Kim SS, Kim YS (1990) Korean mushrooms. Yupoong, Seoul, pp 298–299
Kim JH, Nam JS (1984) Studies on distribution of the mononucleotides in Ganoderma lucidum. Korean J Mycol 12(3):111–116
Kim JH, Lee DH, Lee SH, Choi SY, Lee JS (2004) Effect of Ganoderma lucidum on the quality and functionality of Korean traditional rice wine, yakju. J Biosci Bioeng 97:24–28
Kimura Y, Taniguchi M, Baba K (2002) Antitumor and antimetastic effects on liver triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance. Anticancer Res 22(6A):3309–3318
Kino K, Yamashita A, Yamaoka K, Watanabe J, Tanaka S, Ko K, Shimizu K, Tsunoo H (1989) Isolation and characterization of a new immunomodulatory protein, ling zhi-8 (LZ-8), from Ganoderma lucidum. J Biol Chem 264(1):472–478
Kodama K, Murata K, Nanba H (2004) Administration of a polysaccharide from grifola frondosa stimulates immune function of normal mice. J Med Food 7:141–145
Kohda H, Tokumoto W, Sakamoto K, Fuji M, Hirai Y, Yamasaki K (1985) The biologically-active constituents of Ganoderma lucidum (Fr) karst-histamine release-inhibitory triterpenes. Chem Pharm Bull 33:1367–1373
Komoda Y, Shimizu M, Sonoda Y, Sato Y (1989) Ganoderic acid and its derivatives as cholesterol synthesis inhibitors. Chem Pharm Bull 37(2):531–533
Krishna KV, Karuppuraj V, Perumal K (2016) Antioxidant activity and Folic acid content in indigenous isolates of Ganoderma lucidum. Asian J Pharm Anal 6(4):213–215
Kurtipek GS, Ataseven A, Kurtipek E, Kucukosmanoglu I, Toksoz MR (2016) Resolution of cutaneous sarcoidosis following topical application of Ganoderma lucidum (Reishi Mushroom). Dermatol Ther 6(1):105–109
Lai CS, Yu MS, Yuen WH, So KF, Zee SY, Chang RC (2008) Antagonizing beta-amyloid peptide neurotoxicity of the anti-aging fungus Ganoderma lucidum. Brain Res 1190:215–224
Lakshmi B, Ajith TA, Jose N, Janardhanan KK (2006) Antimutagenic activity of methanolic extract of Ganoderma lucidum and its effect on hepatic damage caused by benzo[a]pyrene. J Ethnopharmacol 107:297–303
Lee S, Park S, Oh JW, Yang C (1998) Natural inhibitors for protein prenyltransferase. Planta Med 64:303–340
Lee JM, Kwon H, Jeong H, Lee JW, Lee SY, Baek SJ, Surh YJ (2001) Inhibition of lipid peroxidation and oxidative DNA damage by Ganoderma lucidum. Phytother Res 15(3):245–249
Li YQ, Wang SF (2006) Anti-hepatitis B activities of ganoderic acid from Ganoderma lucidum. Biotechnol Lett 28:837–841
Liang F (1993) Production of health tonic. CN patent no. 1069738
Lieu CW, Lee SS, Wang SY (1992) The effect of Ganoderma lucidum on induction of differentiation in leukemic U937-Cells. Anticancer Res 12(4):1211–1216
Lin Z-B (2005) Cellular and molecular mechanisms of immunomodulation by Ganoderma lucidum. J Pharmacol Sci 99(2):144–153
Lin J, Lin S, Weng S (1998) Glossy Ganoderma wine and preparation method thereof. CN patent no. 1176999
Lin S-B, Li CH, Lee SS, Kan L-S (2003) Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest. Life Sci 72(21):2381–2390
Lin CC, Yu YL, Shih CC, Liu KJ, Ou KL, Hong LZ, Chen JDC, Chu CL (2011) A novel adjuvant Ling Zhi-8 enhances the efficacy of DNA cancer vaccine by activating dendritic cells. Cancer Immunol Immunother 60:1019–1027
Lindequist U, Niedermeyer THJ, Julich WD (2005) The pharmacological potential of mushrooms. eCAM 2:285–299
Liu RM, Zhong JJ (2011) Ganoderic acid Mf and S induce mitochondria mediated apoptosis in human cervical carcinoma HeLa cells. Phytomedicine 18(5):349–355
Liu J, Shiono J, Shimizu K, Kukita A, Kukita T, Kondo R (2009) Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor. Bioorg Med Chem Lett 19(8):2154–2157
Liu RM, Li YB, Zhong J-J (2012) Cytotoxic and pro-apoptotic effects of novel ganoderic acid derivatives on human cervical cancer cells in vitro. Eur J Pharmacol 681(1):23–33
Liu J, Liu X, Wang L, Wu F, Yang Z (2013a) Neuroprotective effects of ganoderic acid extract against epilepsy in primary hippocampal neurons. Res Opin Anim Vet Sci 3(11):420–425
Liu C, Song Y, Yang N, Tversky JR, Reid-Adam J, Li X-M (2013b) Ganoderic acid β suppressed Th2 responses and induced Th1/Tregs in cultures of peripheral blood mononuclear cells from asthmatic patients. J Allergy Clin Immunol 131(2):AB1
Lokody I (2014) Metabolism: cholesterol promotes breast cancer growth. Nat Rev Cancer 14(1):11
Masuda Y, Inoue H, Ohta H, Miyake A, Konishi M, Nanba H (2013) Oral administration of soluble β-glucans extracted from Grifola frondosa induces systemic antitumor immune response and decreases immunosuppression in tumor-bearing mice. Int J Cancer 133(1):108–119
Mayuzami F, Fujiwara H (1993) Food containing dietary fiber. JP patent 5091854
McKenna D, Jones K, Hughes K (2002) Reishi botanical medicines: the desk reference for major herbal supplements, 2nd edn. The Haworth Herbal Press, Binghamton, NY, pp 825–855
Min BS, Nakamura N, Miyashiro H, Bae KW, Hattori M (1998) Triterpenes from the spores of Ganoderma lucidum and their activity against HIV-1 protease. Chem Pharm Bull 46:1607–1612
Min BS, Gao JJ, Nakamura N, Hattori M (2000) Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against Meth-A and LLC tumor cells. Chem Pharm Bull 48:1026–1033
Miyasaka N, Inoue H, Totsuka T, Koike R, Kino K, Tsunoo H (1992) An immunomodulatory protein, Ling Zhi-8, facilitates cellular interaction through modulation of adhesion molecules. Biochem Biophys Res Commun 186:385–390
Mizushina Y, Hanashima L, Yamaguchi T, Takemura M, Sugawara F, Saneyoshi M, Matsukage A, Yoshida S, Sakaguchi K (1998) A mushroom fruiting body-inducing substance inhibits activities of replicative DNA polymerases. Biochem Biophys Res Commun 249(1):17–22
Moreno AC, Campos PV, Villeda H, Leon RJI, Montiel AE (2011) Ganoderma lucidum reduces kainic acid-induced hippocampal neuronal damage via inflammatory cytokines and glial fibrillary acid protein expression. Proc West Pharmacol Soc 54:77–78
Morigiwa A, Kitabatake K, Fujimoto Y, Ikekawa N (1986) Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum. Chem Pharm Bull 34(7):3025–3028
Murasugi A, Tanaka S, Komiyama N, Iwata N, Kino K, Tsunoo H, Sakuma S (1991) Molecular cloning of a cDNA and a gene encoding an immunomodulatory protein, Ling Zhi-8, from a fungus, Ganoderma lucidum. J Biol Chem 266:2486–2493
Murata T, Ishigami Y, Ishikawa H (1989) Viscous polysaccharide production by Ganoderma. JP patent no. 1121302
Nahata A (2013) Ganoderma lucidum a potent medicinal mushroom with numerous health benefits. Pharmaceut Anal Acta 4(10):1000e159
Naoi Y (1990) Production of beer. JP patent no. 2097373
Nayak A, Nayak RN, Bhat K (2010) Antifungal activity of a toothpaste containing Ganoderma lucidum against Candida albicans—an in vitro study. J Int Oral Health 2(2):51–57
Nieminen P, Karja V, Mustonen AM (2009) Myo-and hepatotoxic effects of cultivated mushrooms in mice. Food Chem Toxicol 47:70–74
Numata K (1988) Health drink vinegar. JP patent no. 63068069
Ogbe AO, Efenu P, Nicholas U, Pam A, Abarshi A, Banyigyi S, Odugbo M, Ogbe AO (2011) Response to treatment of skin ailments in animal patients using aqueous Ganoderma extract. J Environ Agric Food Chem 10:1816–1820
Ooi VEC, Liu F (2000) Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem 7:715–729
Ouyang JJ, Wang YQ, Tang W (2014) Ganoderic acid restores the sensitivity of multidrug resistance cancer cells to doxorubicin. Adv Mater Res 834:573–576
Pan X, Lopez-Olivo MA, Song J, Pratt G, Suarez-Almazor ME (2017) Systematic review of the methodological quality of controlled trials evaluating Chinese herbal medicine in patients with rheumatoid arthritis. BMJ Open 7(3):e013242
Paterson RRM (2006) Ganoderma—a therapeutic fungal biofactory. Phytochemistry 67:1985–2001
Pincemail JJ (1995) Free radicals and antioxidants in human diseases. In: Favier AE, Cadet J, Kalyanaraman B, Fontecave M, Pierre JL (eds) Analysis of free radicals in biological systems. Birkhauser Verlag, Berlin, pp 83–98
Powell M (2015) Medicinal mushrooms—a clinical guide. Mycology Press
Prasad Y, Wesely WE (2008) Antibacterial activity of the bio-multidrug (Ganoderma lucidum) on multidrug resistant Staphylococcus aureus (MRSA). Adv Biotechnol 10:9–16
Quereshi S, Pandey AK, Sandhu SS (2010) Evaluation of antibacterial activity of different Ganoderma lucidum extracts. People’s J Scient Res 3(1):9–14
Rajasekaran M, Kalaimagal C (2012) Cardioprotective effect of a medicinal mushroom, Ganoderma lucidum against adriamycin induced toxicity. Int J Pharmacol 8(4):252–258
Rubel R, Dalla SHS, Bonatto SJ, Bello S, Fernandes LC, di Bernardi R, Gern J, Santos CA, Soccol CR (2010) Medicinal Mushroom Ganoderma lucidum (Leyss Fr) Karst. Triggers immunomodulatory effects and reduces nitric oxide synthesis in mice. J Med Food 13:142–148
Rubel R, Santa HSD, Fernandes LC, Bonatto SJR, Bello S, Figueiredo BC, Filho JHCL, Santos CAM, Soccol CR (2011) Hypolipidemic and antioxidant properties of Ganoderma lucidum (Leyss:Fr) Karst used as a dietary supplement. World J Microbiol Biotechnol 27:1083–1089
Seto SW, Lam TY, Tam HL, Au AL, Chan SW, Wu JH, Yu PH, Leung GP, Ngai SM, Yeung JH, Leung PS (2009) Novel hypoglycemic effects of Ganoderma lucidum water-extract in obese/diabetic (+db/+db) mice. Phytomedicine 16(5):426–436
Sheena N, Ajith TA, Janardhanan KK (2003) Antiinflammatory and antinociceptive activities of Ganoderma lucidum occurring in South India. Pharm Biol 41:301–304
Shiao MS (2003) Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities, and pharmacological functions. Chem Rec 3:172–180
Shiao MS, Lee KR, Lin LJ, Wang CT (1994) Natural products and biological activities of the Chinese medical fungus, Ganoderma lucidum. In: Ho CT, Osawa T, Huang MT, Rosen RT (eds) Food phytochemicals for cancer prevention. II: teas, spices, and herbs. American Chemical Society, Washington, DC, pp 342–354
Sliva D (2003) Ganoderma lucidum (Reishi) in cancer treatment. Integr Cancer Ther (4):358–364
Smith BJ, Sivasithamparam K (2000) Internal transcribed spacer ribosomal DNA sequence analysis for 5 species of Ganoderma from Australia. Mycol Res 104:943–951
Song YS, Kim SH, Sa JH, Jin C, Lim CJ, Park EH (2004) Anti-angiogenic and inhibitory activity on inducible nitric oxide production of the mushroom Ganoderma lucidum. J Ethnopharmacol 90(1):17–20
Srivastava KD, Kattan JD, Zou ZM, Li JH, Zhang L, Wallenstein S, Goldfarb J, Sampson HA, Li XM (2005) The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in murine model of peanut allergy. J Allergy Clin Immunol 115:171–178
Su C, Shiao M, Wang C (2000) Potentiation of ganodermic acid S on prostaglandin E(1)-induced cyclic AMP elevation in human platelets. Thromb Res 99:135–145
Sun J, He H, Jun B, Nozvel X (2004) Antioxidant peptides from fermented mushroom Ganoderma lucidum. J Agric Food Chem 52:6646–6652
Sun LX, Li WD, Lin ZB, Duan XS, Li XF, Yang N, Lan TF, Li M, Sun Y, Yu M, Lu J (2014) Protection against lung cancer patient plasma-induced lymphocyte suppression by Ganoderma lucidum polysaccharides. Cell Physiol Biochem 33(2):289–299
Tamura T, Takahashi T, Matsuda S (1987) Production of fermented food. JP patent 62096063
Tanaka S, Ko K, Kino K, Tsuchiya K, Yamashita A, Murasugi A, Sakuma S, Tsunoo H (1989) Complete amino acid sequence of an immunomodulatory protein, ling zhi-8 (LZ-8) an immunomodulator from a fungus, Ganoderma lucidum, having similarity to immunoglobulin variable regions. J Biol Chem 264:16372–16377
Tasaka K, Akagi M, Miyoshi K, Mio M, Makino T (1988a) Antiallergic constituents in the culture medium of Ganoderma lucidum (I) inhibitory effect of oleic acid on histamine release. Agents Actions 23:153–156
Tasaka K, Mio M, Izushi K, Akagi M, Makino T (1988b) Anti-allergic constituents in the culture medium of Ganoderma lucidum (II). The inhibitory effect of cyclooctasulfur on histamine release. Agents Actions 23:157–160
Terada A, Murata J (1985) Preparation of coffee Containing Ganoderma lucidum. JP patent no. 60262552
Thyagarajan A, Jedinak A, Nguyen H, Terry C, Baldridge LA, Jiang J, Sliva D (2010) Triterpenes from Ganoderma lucidum induce autophagy in colon cancer through the inhibition of p38 mitogen-activated kinase (p38 MAPK). Nutr Cancer 62(5):630–640
Timo HJ, Lindequist U, Mentel R, Gordes D, Schmidt E, Thurow K, Lalk M (2005) Antiviral terpenoid constituents of Ganoderma pfeifferi. J Nat Prod 68:1728–1731
Toth JO, Luu B, Ourission G (1983) Les acides ganoderiques T & Z: triterpenes cytotoxiques de Ganoderma lucidum (Polyporaceae). Tetrahedron Lett 24:1081–1084
Tsujikura S, Higuchi T (1991) Ganoderma lucidum jelly and production thereof. JP patent no. 3127955
Ukiya M, Akihisa T, Tokuda H, Hirano M, Oshikubo M, Nobukuni Y, Kimura Y, Tai T, Kondo S, Nishino H (2002) Inhibition of tumor-promoting effects by poricoic acids G and H and other lanostane-type triterpenes and cytotoxic activity of poricoic acids a and g from Poria cocos. J Nat Prod 65:462–465
van der Hem LG, van der Vliet JA, Bocken CF, Kino K, Hoitsma AJ, Tax WJ (1995) Ling Zhi-8: studies of a new immunomodulating agent. Transplantation 60:438–443
van der Hem LG, van der Vliet JA, Kino K, Hoitsma AJ, Tax WJ (1996) Ling-Zhi-8: a fungal protein with immunomodulatory effects. Transplant Proc 28:958–959
Wachtel-Galor S, Benzie IFF, Tomlinson B, Buswell JA (2003) Lingzhi (Ganoderma lucidum). In: Packer L, Halliwell B, Ong CN (eds) Herbal medicines. Marcel Dekker, New York
Wachtel-Galor S, Tomlinson B, Benzie IF (2004) Ganoderma lucidum (Lingzhi), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study. Br J Nutr 91:263–269
Wagner R, Mitchell DA, Sassakil GL, Amazonas MA, Berovi M (2003) Current techniques for the cultivation of Ganoderma lucidum for the production of biomass, ganoderic acid and polysaccharides. Food Technol Biotechnol 41:371–382
Wang SY, Hsu ML, Hsu HC, Tzeng CH, Lee SS, Shiao MS, Ho CK (1997) The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int J Cancer 70(6):699–705
Wang Y, Zhang L, Li Y, Hou X, Zeng F (2004) Correlation of structure to antitumor activities of five derivatives of a β-glucan from Poria cocos sclerotium. Carbohydr Res 339:2567–2574
Wang G, Zhao J, Liu J, Huang Y, Zhong JJ, Tang W (2007) Enhancement of IL-2 and IFN-gamma expression and NK cells activity involved in the anti-tumor effect of ganoderic acid Me in vivo. Int Immunopharmacol 7:864–870
Wang GJ, Huang YJ, Chen DH, Lin YL (2009) Ganoderma lucidum extract attenuates the proliferation of hepatic stellate cells by blocking the PDGF receptor. Phytother Res 23:833–839
Wasser SP (2005) Reishi or Ling Zhi (Ganoderma lucidum). Encyclopedia of dietary supplements, vol 1, pp 603–622
Wasser SP (2011) Current findings, future trends, and unsolved problems in studies of medicinal mushrooms. Appl Microbiol Biotechnol 89:1323–1332
Wicks SM, Tong R, Wang CZ, O’Connor M, Karrison T, Li S, Moss J, Yuan CS (2007) Safety and tolerability of Ganoderma lucidum in healthy subjects: a double-blind randomized placebo-controlled trial. Am J Chin Med 35(3):407–414
Wu YW, Fang HL, Lin WC (2010) Post-treatment of Ganoderma lucidum reduced liver fibrosis induced by thioacetamide in mice. Phytother Res 24:494–499
Wu GS, Lu JJ, Guo JJ, Li YB, Tan W, Dang YY, Zhong ZF, Xu ZT, Chen XP, Wang YT (2012) Ganoderic acid DM, a natural triterpenoid, induces DNA damage, G1 cell cycle arrest and apoptosis in human breast cancer cells. Fitoterapia 83(2):408–414
Xu J-W, Zhao W, Zhong J-J (2010) Biotechnological production and application of ganoderic acids. Appl Microbiol Biotechnol 87(2):457–466
Yamashita K, Sato T (1994) Healthy candy containing raw material of crude medicine in high concentration and its production. JP patent no. 6113743
Yang BK, Jeong SC, Park JB, Cho SP, Lee HJ, Das S, Yun JW, Lim WJ, Song CH (2001) Swimming endurance capacity of mice after administration of exo-polymer produced from submerged mycelia culture of Ganoderma lucidum. J Microbiol Biotechnol 11:902–905
Yang XJ, Liu J, Ye LB, Yang F, Ye L, Gao JR, Wu ZH (2006) In vitro and in vivo protective effects of proteoglycan isolated from mycelia of Ganoderma lucidum on carbon tetrachloride-induced liver injury. World J Gastroenterol 12:1379–1385
Yao X, Li G, Xu H, Lu C (2012) Inhibition of the JAK-STAT3 signaling pathway by ganoderic acid A enhances chemosensitivity of HepG2 cells to cisplatin. Planta Med 78(16):1740–1748
Yoshii T, Kai S (1984) Preparation of yoghurt by mushroom fungus. JP patent no. 59078641
Yu D (1994) Alcoholic beverage by Ganoderma lucidum fermentation. KR patent no. 9401304
Yu J, Zhai Y (1979) Studies on the constituents of Ganoderma capens (Part I) (author’s transl). Yao Xue Xue Bao 14(6):374
Yuan JP, Wang JH, Liu X, Kuang HC, Huang XN (2006) Determination of ergosterol in Ganoderma spore lipid from the germinating spores of Ganoderma lucidum by high-performance liquid chromatography. J Agric Food Chem 54:6172–6176
Yue QX, Song XY, Ma C, Feng LX, Guan SH, Wu WY, Yang M, Jiang BH, Liu X, Cui YJ, Guo DA (2010) Effects of triterpenes from Ganoderma lucidum on protein expression profile of HeLa cells. Phytomedicine 17(8):606–613
Zhang HN, Lin ZB (2004) Hypoglycemic effect of Ganoderma lucidum polysaccharides. Acta Pharmacol Sin 25:191–195
Zhang GL, Wang YH, Ni W, Teng HL, Lin ZB (2002a) Hepatoprotective role of Ganoderma lucidum polysaccharide against BCG-induced immune liver injury in mice. World J Gastroenterol 8:728–733
Zhang J, Tang Q, Zimmerman-Kordman M, Reutter W, Fan H (2002b) Activation of B lymphocytes by GLIS, a bioactive proteoglycan from Ganoderma lucidum. Life Sci 71(6):623–638
Zhang Y, Lin Z, Hu Y, Wang F (2008) Effect of Ganoderma lucidum capsules on T lymphocyte subsets in football players on living high training low. Br J Sports Med 42:819–822
Zhang J, Tang Q, Zhou C, Jia W, Da Silva L, Nguyen LD, Reutter W, Fan H (2010a) GLIS, a bioactive proteoglycan fraction from Ganoderma lucidum, displays anti-tumour activity by increasing both humoral and cellular immune response. Life Sci 87(19–22):628–637
Zhang Q, Andoh T, Konno M, Lee JB, Hattori M, Kuraishi Y (2010b) Inhibitory effect of methanol extract of Ganoderma lucidum on acute itch-associated responses in mice. Biol Pharm Bull 33:909–911
Zhou S, Gao Y, Chen G, Dai X, Ye J, Gao H (2002) A phase I=II study of a Ganoderma lucidum (Curt.: Fr.) P. Karst. (Ling Zhi, reishi mushroom) extract in patients with chronic hepatitis B. Int J Med Mushrooms 4:321–328
Zhou X, Lin J, Yin Y, Zhao J, Sun X, Tang K (2007) Ganodermataceae: natural products and their related pharmacological functions. Am J Chin Med 35:559–574
Zhu X, Lin Z (2006) Modulation of cytokines production, granzyme B and perforin in murine CIK cells by Ganoderma lucidum polysaccharides. Carbohydr Polym 63:188–197
Ziegenbein FC, Hanssen HP, Konig WA (2006) Secondary metabolites from Ganoderma lucidum and Spongiporus leucomallellus. Phytochemistry 67:202–211
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ahmad, M.F. (2019). Ganoderma lucidum: A Macro Fungus with Phytochemicals and Their Pharmacological Properties. In: Ozturk, M., Hakeem, K. (eds) Plant and Human Health, Volume 2. Springer, Cham. https://doi.org/10.1007/978-3-030-03344-6_21
Download citation
DOI: https://doi.org/10.1007/978-3-030-03344-6_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-03343-9
Online ISBN: 978-3-030-03344-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)